洪 國盛

Medicine & Life Sciences

1. Traumatic Brain Injury 100%
2. Osteoporosis 82%
3. Bile Ducts 77%
4. Spinal Cord Injuries 75%
5. Ligation 74%
6. Thioacetamide 73%
7. Genes 61%
8. Neuroprotection 59%
9. Hepatocytes 56%
10. Apoptosis 55%
11. Melanocyte-Stimulating Hormones 54%
12. Common Bile Duct 52%
13. Genetic Therapy 48%
14. Population 47%
15. Wounds and Injuries 45%
16. Astrocytes 45%
17. Curcumin 43%
18. Radiosurgery 42%
19. Erythropoietin 40%
20. Intracranial Pressure 39%
21. calpain inhibitor III 37%
22. Liver 37%
23. Glioblastoma 36%
24. Tissue Inhibitor of Metalloproteinases 36%
25. Neurofibromatosis 2 35%
26. Glasgow Coma Scale 35%
27. Hyperbaric Oxygenation 34%
28. Liver Cirrhosis 34%
29. Single Nucleotide Polymorphism 33%
30. Renal Dialysis 33%
31. Acute Liver Failure 31%
32. Spinal Fusion 31%
33. Intracranial Hemorrhages 30%
34. Acoustic Neuroma 30%
35. Matrix Metalloproteinase Inhibitors 30%
36. benzyloxycarbonyl-leucyl-glucyl-tyrosine fluoromethyl ketone 29%
37. Plasmids 29%
38. Ankylosing Spondylitis 28%
39. Myopia 28%
40. Hematoma 28%
41. Stroke 27%
42. Rabbits 27%
43. Insulin-Like Growth Factor I 26%
44. calpain inhibitors 26%
45. Survival 25%
46. Brain 25%
47. Bile Acids and Salts 25%
48. Chronic Pain 24%
49. Matrix Metalloproteinases 24%